SEC Form 4 · accession 0001209191-15-085585
ACHILLION PHARMACEUTICALS INC · ACHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Verwiel
Director
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070336
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.13 | Dec 14, 2015 | A | 30,000 | A | Dec 14, 2015 | Dec 14, 2025 | Common Stock | 30,000 | 30,000 | D |